# Intracranial Hemorrhage Risk of Intensive Statin in Acute Ischemic Stroke With Cerebral Microbleeds

> **NCT05589454** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Sichuan Provincial People's Hospital** · enrollment: 344 (estimated)

## Conditions studied

- Acute Ischemic Stroke
- Cerebral Microbleeds

## Interventions

- **DRUG:** Atorvastatin Calcium tablets 80mg
- **DRUG:** Atorvastatin Calcium tablets 20mg

## Key facts

- **NCT ID:** NCT05589454
- **Lead sponsor:** Sichuan Provincial People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2023-01
- **Primary completion:** 2026-12
- **Final completion:** 2027-06
- **Target enrollment:** 344 (ESTIMATED)
- **Last updated:** 2022-10-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05589454

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05589454, "Intracranial Hemorrhage Risk of Intensive Statin in Acute Ischemic Stroke With Cerebral Microbleeds". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT05589454. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*